PIK3CA and p53 Mutations by Next Generation Sequencing in Lymphoepithelioma-Like Carcinoma of the Endometrium

<table class="fixed-width table-group" id="tab1"><tr><td><table class="table"><colgroup><col style="width:5.25em"/><col style="width:4.53em"/><col style="width:4.67em"/><col style="width:3.78em"/></colgroup><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">AKT1</td><td class="align_center">DICER1</td><td class="align_center">FOXL2</td><td class="align_center">POLE</td></tr><tr><td class="align_left">BRAF</td><td class="align_center">ERBB2</td><td class="align_center">KRAS</td><td class="align_center">PTEN</td></tr><tr><td class="align_left">CDKN2A</td><td class="align_center">FBXW7</td><td class="align_center">PIK3CA</td><td class="align_center">RB1</td></tr><tr><td class="align_left">CTNNB1</td><td class="align_center">FGFR2</td><td class="align_center">PIK3R1</td><td class="align_center">TP53</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Cancer hotspot panel used by NGS.</div>

Case Reports in Pathology

tab1

Table 1

Table 1: PIK3CA and p53 Mutations by Next Generation Sequencing in Lymphoepithelioma-Like Carcinoma of the Endometrium 